RNAC Stock-Based Compensation
Cartesian Therapeutics Inc · Stock-Based Compensation
RNAC Stock-Based Compensation
Latest reported$9.24Mperiod ending
RNAC Stock-Based Comp ($1.22M → $9.24M)
Annual stock-based compensation
High-resolution chart · PNG
RNAC stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 10,521,000 | |
| 6,582,000 | |
| 22,524,000 | |
| 11,194,000 | |
| 7,720,000 | |
| 5,422,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 1,224,000 |